FindTrial
Sign In

Esophageal mucosal changes in achalasia cardia and reversibility after per oral endoscopic myotomy: A pilot study

Esophageal mucosal changes in long standing achalasia cardia and reversibility after per oral endoscopic myotomy ( POEM )- A pilot study - POEM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/026251
Enrollment
30
Registered
2020-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K23- Disorders of esophagus in diseasesclassified elsewhere

Interventions

Intervention1: Per oral endoscopy myotomy: The per-oral endoscopic myotomy, or POEM, is a minimally invasive surgical procedure for the treatment of achalasia wherein the inner circular muscle layer o

Sponsors

Asian institute of GastroenterologyAIG Hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients of achalasia cardia who will undergo POEM and an esophageal mucosal biopsy at 3 months of follow up

Exclusion criteria

Exclusion criteria: •Patients of achalasia cardia not undergoing POEM or an esophageal mucosal biopsy at 3 months of follow up •Upper gastro-intestinal surgically altered anatomy ( apart from previous Heller Myotomy ) •Pregnancy •Patients not giving consent for participation •End Point( Length of follow up )- 3 months after POEM - single follow up.

Design outcomes

Primary

MeasureTime frame
To study mucosal changes in patients with achalasia cardiaTimepoint: 12 weeks—

Secondary

MeasureTime frame
To study potential malignant histopathological findings in long standing achalasia cardia Timepoint: 12 weeks—

Countries

India

Contacts

Public ContactRAJESH GOUD MARAGONI

Asian institute of Gastroenterology/AIG Hospitals

pranavambardekar@gmail.com9762046749

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026